BlackRock, Inc. 13D and 13G filings for LB Pharmaceuticals Inc Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-29 3:19 pm Purchase | 2026-06-30 | 13G | LB PHARMACEUTICALS INC LBRX | BlackRock Inc. BLK | 1,796,543 6.300% | 518,767 (+40.60%) | Filing |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | LB PHARMACEUTICALS INC LBRX | BlackRock Inc. BLK | 1,277,776 5.100% | 1,277,776 (New Position) | Filing |